Narcan Nasal Product

PreclinicalSmall molecule

JJohns Hopkins Bloomberg School of Public Health

Narcan Nasal Product is one of 16 small molecule programs targeting Overdose. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

OverdoseActive, not recruiting

OverdosePreclinical

Active, not recruiting

Competition

Competitive Landscape

23 competitors in Overdose

#DrugCompanyPhaseTrials

Narcan

SScienture

Approved

2 2

Suboxone

Haldol

1 4

Ativan

BBausch Health Americas, Inc.

Phase 2

1 5

Cysteine Hydrochloride

Novartis

Phase 1

1 6

Acetadote

AArbor Pharmaceuticals, Inc.

Phase 1

1 7

Naloxone Intranasal

NNorwegian University of Science and Technology

Phase 3

1 8

Sublocade

IIndivior Inc.

Phase 3

1 9

Intravenous

IIsfahan University of Medical Sciences

Phase 2

1 10

MS Contin

Merck & Co.

Preclinical

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Overdose1 trial

An Evaluation of a Social Network Intervention for Primary and Secondary Prevention of Opioid Overdoses

Completed·JJohns Hopkins Bloomberg School of Public Health·N/A·NCT04212364·614 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Narcan Nasal Product. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Narcan Nasal Product compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Narcan Nasal Product. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Johns Hopkins Bloomberg School of Public Health company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: JJohns Hopkins Bloomberg School of Public Health

Narcan Nasal Product

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Overdose1 trial

References

Drug Info

Quick Facts

Related News